{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04803058",
            "orgStudyIdInfo": {
                "id": "TCD601A202"
            },
            "organization": {
                "fullName": "ITB-Med LLC",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE)",
            "officialTitle": "A Safety and Tolerability Study of TCD601 (Siplizumab), a Human Anti-CD2 Antibody, Combined With Donor Bone Marrow Cell Infusion and Non-Myeloablative Conditioning, Including Fludarabine and Cyclophosphamide, for Tolerance Induction in Living Donor Renal Transplantation",
            "acronym": "PERSPECTIVE",
            "therapeuticArea": [
                "Nephrology and Renal Diseases"
            ],
            "study": "a-study-of-in-the-induction-of-tolerance-in-renal-transplantation-perspective"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-12-14",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2030-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-03-14",
            "studyFirstSubmitQcDate": "2021-03-14",
            "studyFirstPostDateStruct": {
                "date": "2021-03-17",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-02",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "ITB-Med LLC",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to evaluate if TCD601 can induce allogeneic tolerance in living donor renal transplant recipients"
        },
        "conditionsModule": {
            "conditions": [
                "Kidney Transplantation"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 18,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Arm 1",
                    "type": "EXPERIMENTAL",
                    "description": "TCD601administered with non-myeloablative conditioning and standard of care immunosuppression",
                    "interventionNames": [
                        "Biological: TCD601"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "TCD601",
                    "description": "Investigational Product",
                    "armGroupLabels": [
                        "Arm 1"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "The safety, tolerability and activity of a Siplizumab-based conditioning regimen to induce renal allograft tolerance",
                    "description": "The proportion of patients off immunosuppression with good safety and tolerability",
                    "timeFrame": "24 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Incidence of biopsy proven acute rejection, death, and graft loss",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "The incidence of DSA",
                    "timeFrame": "24 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Able to understand the study requirements and provide written informed consent before any study assessment is performed\n* Male or female patients \u2265 18 to 65 years of age\n* Recipient of a renal transplant from a non-human leukocyte antigen (HLA)-identical but at least haploidentical, ABO compatible living donor\n\nKey Exclusion Criteria:\n\n* Women of child-bearing potential, unless willing to comply with the use of highly effective methods of contraception as defined by the protocol\n* A history of cancer other than basal cell carcinoma of the skin or carcinoma in situ of the cervix\n* Recipient with anti-HLA donor-specific antibody (DSA)",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Shannon Zentmeyer, BSN",
                    "role": "CONTACT",
                    "phone": "347-326-1985",
                    "email": "shannon.zentmeyer@itb-med.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Nick Hryciw, MA",
                    "affiliation": "ITB-MED",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Chicago",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60637",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Research Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Research Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Mayo Clinic",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Research Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                },
                {
                    "facility": "Weill Cornell",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Research Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Samsung Medical University",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Research Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M6727",
                    "name": "Cyclophosphamide",
                    "relevance": "LOW"
                },
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M283230",
                    "name": "Fludarabine",
                    "relevance": "LOW"
                },
                {
                    "id": "M225513",
                    "name": "Fludarabine phosphate",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}